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a b s t r a c t
Initial embryonic determination of artery or vein identity is regulated by genetic factors that work in
concert to specify the endothelial cell's (EC) fate, giving rise to two structurally unique components of
the circulatory loop. The Shh/VEGF/Notch pathway is critical for arterial speciﬁcation, while the orphan
receptor nr2f2 (COUP-TFII) has been implicated in venous speciﬁcation. Studies in mice have shown that
nr2f2 is expressed in venous but not arterial ECs, and that it preferentially induces markers of venous cell
fate. We have examined the role of nr2f2 during early arterial–venous development in the zebraﬁsh
trunk. We show that expression of a subset of markers of venous endothelial identity requires nr2f2,
while the expression of nr2f2 itself requires sox7 and sox18 gene function. However, while sox7 and sox18
are expressed in both the cardinal vein and the dorsal aorta during early trunk development, nr2f2 is
expressed only in the cardinal vein. We show that Notch signaling activity present in the dorsal aorta
suppresses expression of nr2f2, restricting nr2f2-dependent promotion of venous differentiation to the
cardinal vein.
Published by Elsevier Inc.
Introduction
The proper functioning of the circulatory system as a closed
loop continually re-circulating blood to and from peripheral
tissues depends on the fundamental division of the circulatory
system into two distinct and separate yet completely intertwined
and interconnected networks of blood vessels – veins and arteries
– that direct blood to and from the heart, respectively. Although
the existence of these two distinct types of blood vessels has been
appreciated for centuries, we have only begun to understand the
molecular pathways leading to their differential speciﬁcation and
identity. In the developing zebraﬁsh trunk, hedgehog signaling
regulates arterial differentiation via downstream activation of
vascular endothelial growth factor (VEGF) and Notch pathways.
Sonic hedgehog (SHH) secreted from the midline axial mesoderm
promotes up-regulation and secretion of VEGF in adjacent somitic
tissue, which in turn promotes Notch pathway activation and
arterial differentiation in the juxtaposed assembling trunk dorsal
aorta (Lawson et al., 2001; Lawson et al., 2002). VEGF and Notch
signaling have also been shown to promote arterial differentiation
in developing mice and other models (reviewed in (Swift and
Weinstein, 2009)). While arterial speciﬁcation is driven by the
preferential activation of the Shh/VEGF/Notch pathways, it had
been believed that venous differentiation was a default differen-
tiation pathway for endothelial cells (Thurston and Yancopoulos,
2001).
Recently, however, this view was challenged by the identiﬁca-
tion of genetic factors required for proper venous differentiation.
Chicken ovalbumin upstream promoter-transcription factor II
(“COUP-TFII;” recently designated “nuclear receptor subfamily 2,
group F, member 2,” or “NR2F2” in zebraﬁsh) has been shown to
act as a positive mediator of venous speciﬁcation in mice. The
murine COUP-TFII gene is speciﬁcally expressed in venous but not
arterial ECs, and is required for proper vascular morphogenesis.
COUP-TFII knockout mice die at approximately E10.5 following
severe hemorrhage and edema due to enlarged blood vessels,
improper development of the atria and sinus venosus, and mal-
formed cardinal veins (Pereira et al., 1999). Endothelial-speciﬁc
targeted disruption of COUP-TFII results in ectopic expression of
arterial markers in the cardinal vein, while ectopic pan-endothelial
over-expression of COUP-TFII results in fusion of arteries and veins,
similar to phenotypes observed in Neuropilin1 -/- or Notch1-/-
mice (You et al., 2005). These and other results from mice and
cultured cells have led to the proposal that COUP-TFII promotes
venous identity by down-regulating pro-arterial Notch signaling,
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thereby releasing expression of venous factors from Notch-
mediated repression and preventing Notch-mediated activation of
arterial gene expression (Chen et al., 2012). However, while knock-
down of nr2f2 in zebraﬁsh does result in reduced venous ephb4 and
ﬂt4 expression, it does not result in ectopic venous expression of
arterial markers grl and efnb2a (Aranguren et al., 2011), suggesting
additional investigation is needed to fully elucidate the role of nr2f2
in vascular development and differentiation.
In this manuscript, we further examine the role of nr2f2 during
early arterial–venous development in the zebraﬁsh trunk axial vascu-
lature. We show that expression of nr2f2 requires endothelial sox7 and
sox18 gene function, while expression of some but not all markers of
venous identity requires nr2f2. Importantly, our results also suggest
that in addition to promoting arterial gene expression Notch signaling
in the dorsal aorta suppresses expression of nr2f2, restricting nr2f2-
dependent venous gene expression to the cardinal vein.
Materials and methods
Zebraﬁsh
Zebraﬁsh lines used and reported elsewhere were wild-type EK,
cloche mutant (Stainier et al., 1995), Tg(ﬂi1a:EGFP)y1 (Lawson and
Weinstein, 2002), Tg(Tp1bglob:hmgb1-mCherry)h11 (Parsons et al.,
2009), and Tg(UAS:N3ICDmyc) (Scheer and Campos-Ortega, 1999).
The Tg(efnb2a:eGFP) line was generated using a transgene construct
in which cytoplasmic EGFP is driven by 10.2 kb fragment of DNA
upstream from the translation start site of efnb2a (efnb The Tg(ﬂi1a:
GV-EcRF0) line was generated using a transgene construct in which a
drug inducible Gal4-VP16 element, GV-EcRF0 (Esengil et al., 2007), is
driven by a minimal ﬂi1a promoter/enhancer element. Zebraﬁsh em-
bryos and strains were maintained as described (Kimmel et al., 1995).
in situ hybridization and immunohistochemistry
Whole-mount RNA in situ hybridization was carried out as
previously described (Pham et al., 2007). Dual-color whole mount
RNA ﬂuorescent in situ hybridization was carried as previously
described (Hauptmann and Gerster, 1994). Antisense probes for
kdrl, efnb2a, grl, tbx-20, dab2, ephB4a, ﬂi1a, and cdh5 were
prepared as described (Fouquet et al., 1997; Lawson et al., 2002;
Siekmann and Lawson, 2007; Thompson et al., 1998; Yaniv et al.,
2006). Antisense probes for nr2f2 (full length and short form),
sox7, and sox18 were prepared from cDNA using primers listed in
Supplementary Table 1. Amplicons were cloned in pENTR-D/TOPO
(Invitrogen) vectors. Antisense probes for lyve1 and stab1 were
obtained from commercially available clones (Open Biosystems,
7998534 and 8998853). DIG-labeled antisense riboprobes were
synthesized using the DIG Labeling Kit (Roche). Immunostaining
was performed as described (Yaniv et al., 2006).
Cloning and transgene construction
Full-length nr2f2, sox7, and sox18 were ampliﬁed from EK
cDNA. The GVEcRF0 cassette was ampliﬁed from pCS2þGVEcRF0
(Esengil et al., 2007). Xenopus laevis Su(H)DBM was ampliﬁed from
pCS-XSu(H)DBM (Wettstein et al., 1997). Plasmids containing nr2f2
chimeras were made after amplifying a truncated sequence of
nr2f2 (aka ‘Ct’) from full length nr2f2. The truncated nr2f2 was
subsequently cloned into either pcGlobin2-VP16 (Ro et al., 2004)
or ENG-N backbone (Kessler, 1997) to create an activating (referred
to as “VCt” in this text) or a repressing (“ECt”) chimera for nr2f2.
VCt, ECt, full length nr2f2 (“CF”), sox7, sox18, GV-EcRF0, and
XSu(H)DBM were cloned into Gateway compatible pME plasmids.
The self-cleaving viral 2A peptide sequence (Provost et al., 2007;
Szymczak et al., 2004) was used to co-translationally link nr2f2
chimeras to cerulean ﬂuorescent protein, allowing stoichiometric
production of both proteins.
Endothelial speciﬁc pI-SceI(kdrl-CeruleanFP-2A-VCt), pI-SceI
(kdrl-CeruleanFP-2A-ECt), pI-SceI(kdrl-CeruleanFP-2A-CF), Tol2
(ﬂi1a:GVEcRF0), and pI-SceI(kdrl-Su(H)DBM-2A-mCherry) con-
structs were assembled using Gateway technology (Kwan et al.,
2007; Provost et al., 2007; Villefranc et al., 2007).
A list of primers used for cloning can be found in Supplementary
Table 1.
Morpholino and transgene microinjections
Morpholino (Gene Tools) injections were performed at the
described doses into 1- to 2-cell stage embryos. Morpholinos used
in this study are as follows: nr2f2 translation blocking MO
(translation start site underlined), 50-AGCCTCTCCACACTACCATTGC-
CAT-30; nr2f2 exon1 splice donor MO, 50-AACAAAAATCCGAA-
TACCTTCCCGT-30; nr2f2 translation block mismatch control, 50-
AGgCTgTCCACAgTACCATaGCgAT-30; sox7 translation blocking MO
(Cermenati et al., 2008), 50-ACGCACTTATCAGAGCCGCCATGTG-30;
sox18 translation blocking MO (Cermenati et al., 2008), 50-TATT-
CATTCCAGCAAGACCAACACG-30. Tol2 and pI-SceI plasmid DNA
injections were performed as previously described (Grabher et
al., 2004; Kawakami et al., 2000). 100 pg of Tol2 based constructs
and 45 pg of pI-SceI plasmids were injected for each experiment.
Microscopy
RNA in situ hybridization images were captured with a ProgRes
C14 camera mounted on a Leica MZ12 stereo microscope, or with
LAV camera/software on a LM205 stereo microscope. Confocal
microscopy of transgenic and immunostained embryos was per-
formed using an Olympus FluoView 1000 microscope.
qRT-PCR analysis
Total cellular RNA from experimental embryos was isolated using
Trizol reagent and treated with DNAse I. For all gene analysis, only
trunks excised at the level of the ﬁrst somite were collected, except
for prox1a in which whole embryos were used. Brieﬂy, heads and
yolks were removed from 8–10 embryos by a scalpel prior to the
addition of Trizol reagent to the excised trunks (within a given
experiment the same number of embryos were used for preparation
of cDNA for each sample). Total cDNA was synthesized using iScript
cDNA Synthesis Kit (Bio-Rad) and qPCR analysis was carried out
using iQ SYBR Green Supermix on a Bio-Rad CFX96 with ef1a used as
a reference gene. Bio-Rad CFX Manager software was used to
quantify gene expression levels and all analysis conforms with MIQE
guidelines (Bustin et al., 2009).
A list of primers used for qPCR can be found in Supplementary
Table 2.
Drug treatment
Dechorionated Tg(Tp1bglob:hmgb1-mCherry)h11 embryos were
treated with either 100 uM DAPT (Sigma) in 0.2% DMSO or in 0.2%
DMSO alone as a control beginning at 6–8 hpf. Tg(UAS:N3ICDmyc);
Tg(ﬂi1a:GV-EcRF0) double transgenic ﬁsh were treated with either
100 nM TBF (Sigma) in 0.05% DMSO or in 0.05% DMSO alone as a
control beginning at 6–8 hpf.
Measuring Notch reporter output
For each experimental condition, ImageJ software was used to
highlight and count the number of individual mCherry-positive
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Fig. 1. Expression of nr2f2 in developing veins in the zebraﬁsh. (A) Schematic diagram of a 1 dpf zebraﬁsh (modiﬁed from (Kimmel et al., 1995)) with a red box showing the
approximate position of images in B–G. (B–D) Whole mount in situ hybridization of the trunks of 24 hpf (B) and 48 hpf (C and D) zebraﬁsh embryos probed for nr2f2. (E–G)
Two-color ﬂuorescent in situ hybridization of the trunk of a 24 hpf animal probed for kdrl (in red; panels E and G) and nr2f2 (green; panels F and G). Images are all lateral
views of the trunks of whole mount stained animals (anterior to the left) except for panel D, which shows a transverse thick section through the trunk (the red line in panel C
indicates the plane of section shown in panel D). Arrows in panels B, D, and G point to posterior cardinal vein expression of nr2f2, while arrowheads in panels D and G note
the position of the dorsal aorta. Rostral is to the left and dorsal is up in all image panels. Scale bars, (B, C, E, F, and G) 100 mm, (D) 50 mm.
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Fig. 2. nr2f2 function is required for proper venous gene expression in the zebraﬁsh vasculature. (A–D) Transmitted light (A and B) and green ﬂuorescent light (C and D)
images of control (A and C) and nr2f2 morpholino injected (B and D) Tg(ﬂi1a-EGFP)y1 transgenic animals. (E–L) Whole mount in situ hybridization of 24 hpf control (top) and
nr2f2 morpholino injected (bottom) zebraﬁsh embryo trunks probed for ephb4a (E), stab1 (F), lyve1 (G), sox7 (H), efnb2a (I), grl (J), tbx20 (K), and sox18 (L). Blue arrowheads
note posterior cardinal vein gene expression, while red arrows note dorsal aorta gene expression. The inset numbers in panels F–L show the number of in situ-stained nr2f2
MO-injected embryos exhibiting the phenotype shown in the image panel over the total number of embryos examined. (M) Quantitative RT-PCR measurement of gene
expression in excised trunks (see Materials and Methods) of 24 hpf control and nr2f2 morpholino injected animals. Values are all normalized to control gene expression
levels, which are set equal to 1. Rostral is to the left and dorsal is up in all image panels. Scale bars, (A and B) 500 mm, (C–L) 100 mm.
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ﬂuorescent cells from separate, standard-sized boxed regions
placed over the neural tube and the dorsal aorta. The ratio of
measured mCherry-positive cells in the dorsal aorta box versus
mCherry-positive cells in the neural tube box was calculated to
give the relative vascular notch reporter activity in each animal.
Identically sized boxes placed in equivalent positions were used
for measuring reporter ﬂuorescence in the neural tube and dorsal
aorta in each animal measured. The values reported in the inset
numbers in Fig. 3(G)–(K) are each normalized to the control value
(Fig. 3(G)) to provide a ﬁnal measurement of total notch activation.
Five embryos were examined for each condition, with quantitation
performed on one representative animal per condition (displayed
in the image panels in Fig. 3(G)–(K)).
Results
nr2f2 is expressed in the posterior cardinal vein during early zebraﬁsh
trunk vascular development
We used whole mount ISH to analyze the spatial and temporal
expression proﬁle of zebraﬁsh nr2f2. We performed analysis with both
a full open reading frame zebraﬁsh nr2f2 probe and with a shorter,
highly speciﬁc zebraﬁsh nr2f2 probe against only nucleotides 1–240 of
the open reading frame. Similar results were obtained with both
antisense probes and images presented are from analysis with the full
length probe. nr2f2 expression is not detected prior to the 3 somite
stage. Expression is detected in the hindbrain rhombomeres and
anterior somites can be detected at 3 somites (Supp. Fig. 1). By the
15 and 20 somite stages, expressionwithin the central nervous system
is clearly observed in the telencephalon, ventral anterior midbrain,
hindbrain rhombomeres as well as in the otic vesicles, pectoral ﬁn
buds, and developing spinal cord of the trunk (Supp. Fig. 1). While
cranial and spinal cord expression remains robust throughout zebra-
ﬁsh development, weak expression of nr2f2 is ﬁrst observed in the
posterior cardinal vein, but not in the dorsal aorta, at 24 hpf (Fig. 1(A)
and (B)). This expression persists through 48 hpf (Fig. 1(D)–(G)), in
agreement with a previously recorded expression proﬁle of nr2f2
(Aranguren et al., 2011). To conﬁrm posterior cardinal vein-speciﬁc
expression of nr2f2, we performed two color ﬂuorescent ISH to
compare expression proﬁles of nr2f2with the pan-endothelial expres-
sion of kdrl. While kdrl was observed in both the posterior cardinal
vein and dorsal aorta (Fig. 1(E) and (G), red), nr2f2was restricted to the
posterior cardinal vein (Fig. 1(F) and (G); red and green colocalize in
the PCV). Endothelial expression was also conﬁrmed by showing loss
of expression in the presumptive ECs of cloche mutant embryos
(Stainier et al., 1995) that lack most endothelium (Fig. 4(D) and data
not shown).
Reduction in nr2f2 results in loss of venous markers without
corresponding increase in arterial markers
To analyze the effect of reduction of nr2f2 expression on vascular
development, we used antisense morpholino oligonucleotides (MO)
that targeted either the ATG start site of nr2f2 translation (ATG MO,
MO1), or the exon 1 splice donor site (splice MO, MO2), both of which
were effective at reducing normal nr2f2 transcript levels (Supp Fig. 2).
Injections of either MO at 5 or 10 ng doses resulted in embryonic
lethality after 24 hpf with severe morphological defects and edema,
making analysis of vascular development impossible (data not
shown). At 2.5 ng most embryos developed with reasonably normal
overall and vascular morphologies, and displayed only a slight
developmental delay compared to control ﬁsh injected with a control
mismatch morpholino (Fig. 2(A)–(D)). Using this 2.5 ng dose of nr2f2
MO, we performed whole mount in situ hybridization and quantita-
tive RT-PCR to analyze the expression of known arterial, venous, or
pan-endothelial markers in the trunk vasculature of nr2f2 deﬁcient
24 hpf animals compared to their control siblings (Fig. 2(E)–(M)). We
observed signiﬁcant decreases in expression of prox1 and early vein-
restricted marker lvye1 in morphant embryos (Fig. 2(G) and (M)) and
modest decrease in vein-restricted marker stab1 (Fig. 2(F) and (M)),
but no change in expression of vein-restricted markers ephb4 and
dab2 by qRT-PCR (Fig. 2(M)). We also saw no change in expression of
arterial-restricted markers efnb2a, grl, and tbx20 (Fig. 2(I), (J), (K), and
(M)). The expression of the sox7 and sox18 genes, previously
implicated in arterial–venous fate decisions in the zebraﬁsh
(Cermenati et al., 2008; Herpers et al., 2008; Pendeville et al.,
2008), was also unchanged in nr2f2 deﬁcient animals (Fig. 2(H),
(L) and (M)). Other pan-endothelial markers including ﬂi1a, kdrl, and
cdh5 were also unchanged (data not shown).
Since higher doses of nr2f2 morpholinos were associated with
signiﬁcant developmental abnormalities and lethality, likely due
to the earlier essential functions of nr2f2 in the nervous system
and/or other tissues, we used transgenesis to speciﬁcally target
endothelial cells for nr2f2 activation or silencing using “activating”
or “repressing” nr2f2 chimeras, respectively. Previous reports have
described methods for fusing a truncated version of nr2f2 to either
the engrailed repressor domain or the VP16 activating domain
(Naka et al., 2008). We placed full-length nr2f2 or these chimeric
proteins together with cerulean ﬂuorescent protein (to mark
expressing cells) under the control of the vascular-speciﬁc zebra-
ﬁsh kdrl promoter to generate constructs for endothelial-restricted
expression of either wild type full-length nr2f2 (kdrl-CF), “activat-
ing” protein containing VP16 fused to an nr2f2 polypeptide with
its endogenous transactivation domain removed (kdrl-VCt). or
“repressing” protein containing Engrailed fused to an nr2f2 poly-
peptide with its endogenous transactivation domain removed
(kdrl-ECt) (Supp. Fig. 3(A)–(D)). When these constructs were
injected into zebraﬁsh embryos we found that endothelial ex-
pression of “repressing” kdrl-ECt resulted in suppression of
venous-speciﬁc lyve1 expression similar to that observed in nr2f2
MO-injected animals (Fig. 3 C, E, Q). In contrast, endothelial
expression of either wild type nr2f2 or “activating” kdrl-VCt did
not signiﬁcantly alter lyve1 expression (Fig. 3D,F,Q).
nr2f2 does not regulate Notch in the zebraﬁsh vasculature
Previous studies have reported that nr2f2 modulates venous
identity in mice by regulating Notch expression in the developing
vascular system (Chen et al., 2012; You et al., 2005). To examine the
role of nr2f2 in regulating Notch in zebraﬁsh, we injected nr2f2MO
or our vascular nr2f2 chimera-expressing constructs into either a
Tg(Tp1bglob:hmgb1-mCherry)h11 (“Tp1:mCherry”) Notch reporter trans-
genic line (Parsons et al., 2009) or into a Tg(efnb2a:eGFP) Notch
responsive transgenic line. We found no change in the level of
ﬂuorescent protein expressed in the vasculature in either of these
transgenic lines upon injection of nr2f2 MO, or kdrl-CF, kdrl-VCt, or
kdrl-ECt constructs (Fig. 3(G)–(K) and Supp. Fig. 4). Treatment with the
Notch inhibitor DAPT did cause strong reduction in Tg(Tp1bglob:
hmgb1-mCherry)h11 and Tg(efnb2a:eGFP) transgenic reporter expression,
however, conﬁrming that these lines are indeed responsive to reduced
Notch signaling (Supp. Fig. 5). We also found no change in expression
levels of the Notch-responsive gene efnb2a in nr2f2 morpholino or
chimera-injected animals (Fig. 3(L) (Q)). Our results indicating that
Notch signaling is not regulated by nr2f2 in zebraﬁsh are consistent
with previously published results showing that expression of efnb2a
and grl are not affected in nr2f2 morphants (Aranguren et al., 2011).
nr2f2 is regulated by sox7 and sox18 in zebraﬁsh
A number of previous publications have reported that the
Sry-related HMG box (Sox) genes sox7 and sox18 are involved in
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regulating arterial–venous speciﬁcation in zebraﬁsh, although the
precise nature of this regulation remains unclear (Cermenati et al.,
2008; Herpers et al., 2008;Pendeville et al., 2008 ). We used the
same sox7 and sox18 morpholinos used in Cermenati et al., at the
same doses, to determine whether sox7 and/or sox18 function are
required for expression of nr2f2. Injection of sox7 or sox18
Fig. 3. nr2f2 does not regulate Notch in the zebraﬁsh vasculature. (A) Schematic diagram of a 1 dpf zebraﬁsh (modiﬁed from (Kimmel et al., 1995)) with a red box showing
the approximate position of images in B–V. (B–F) Whole mount in situ hybridization of 24 hpf zebraﬁsh probed for lyve1. (G–K) Red ﬂuorescent confocal micrographs of
24 hpf Tg(Tp1bglob:hmgb1-mCherry)h11 (“Tp1:mCherry”) transgenic zebraﬁsh. Inset numbers show quantitative measurements of trunk vascular mCherry ﬂuorescence in a
single representative injected ﬁsh normalized to trunk neural mCherry ﬂuorescence and to values in untreated controls (G). See Materials and Methods for additional
information on measurements. (L–P) Whole mount in situ hybridization of 24 hpf zebraﬁsh probed for efnb2a. Animals in image panels B–P were either untreated (B, G and
L), injected with nr2f2 MO (C, H and M), injected with kdrl-CF (Full length nr2f2 under the control of the kdrl promoter; D, I and N), injected with kdrl-ECt (chimeric protein
with nr2f2 lacking the transactivation domain fused to engrailed repressor domain; E, J and O), or injected with kdrl-VCt (chimeric protein with nr2f2 lacking the
transactivation domain fused to VP16; F,K,P). The inset numbers in panels C–F and M–P show the number of in situ-stained embryos exhibiting the phenotype shown in the
image panel over the total number of embryos examined. (Q) Quantitative RT-PCR measurement of gene expression in excised trunks of 24 hpf animals (see Materials and
Methods). Values are all normalized to control gene expression levels, which are set equal to 1. Rostral is to the left and dorsal is up in all image panels. Scale bar, 100 mm.
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morpholinos alone did not cause signiﬁcant change in nr2f2
expression (data not shown), but dual morpholino (DMO) knock-
down of both sox7 and sox18 together resulted in strong reduction
in nr2f2 expression in the PCV, although neural tube expression
was not detectably altered (Fig. 4(A and B)). Quantitative RT-PCR of
either whole embryo or excised trunk sections of pooled control
and Sox DMO embryos showed that trunk levels of nr2f2 were
reduced by approximately 50%, while levels of lyve1 were more
strongly reduced (Fig. 4(C)). The 50% reduction in nr2f2 likely
reﬂects reasonably complete loss of the vascular expression of
nr2f2, since measurement of excised trunk expression levels by
qRT-PCR showed that the reduction in nr2f2 in sox7/sox18 DMO
embryos was comparable to that observed in cloche mutant
(Stainier et al., 1995) animals that virtually lack all endothelium
(but that also retain the neural tube expression of nr2f2; data not
shown), and was not further reduced by knocking down sox7 and
sox18 in the cloche mutant background (Fig. 4D).
nr2f2 is regulated by Notch in zebraﬁsh
Our results and those of others (Aranguren et al., 2011) suggest
that in the zebraﬁsh nr2f2 is not regulating Notch, unlike nr2f2/
COUP-TFII in mice. Furthermore, some recent in vitro data suggests
that nr2f2 can be a target of Notch signaling in at least some
contexts. Ectopic expression of “activated” Notch intracellular
domain (ICD) or Notch target transcription factors Hey1 and
Hey2 represses nr2f2 expression in cultured lymphatic endothelial
cells (Kang et al., 2010). To explore whether Notch acts upstream
of nr2f2 in the zebraﬁsh vasculature, we began by examining
whether endothelial-speciﬁc activation of Notch signaling
represses nr2f2 expression, using binary transgenic inducible
expression of Notch3 intracellular domain (N3ICD) in endothelium
in vivo. We generated ﬁsh carrying a vascular-speciﬁc,
tebufenozide-inducible GAL4 fusion protein (Tg[ﬂi1a:GVEcRF]))
and crossed these to ﬁsh we have employed previously to
inducibly activate Notch signaling (Lawson et al., 2001) that carry
a myc-tagged UAS-driven N3ICD transgene (Tg[UAS:N3ICDmyc])
(Supp. Fig. 3(E)). Tebufenozide-induced activation of N3ICD prior
to the onset of vascular development resulted in reduction in nr2f2
expression in the PCV but not in the neural tube in Tg(UAS:
N3ICDmyc);Tg(ﬂi1a:GV-EcRF0) double transgenic ﬁsh (Fig. 5
(A) and (B)). Since ectopic endothelial activation of Notch signaling
resulted in reduced nr2f2 expression, we also examined whether
suppression of Notch signaling by endothelial-speciﬁc expression
of a Notch signaling dominant-negative suppressor of hairless
DNA binding domain mutant (Su[H]DBM) might cause increased
nr2f2 expression. To do this, we generated a construct to drive
expression of Su[H]DBM under the control of the kdrl promoter
(kdrl:Su[H]DBM-2A-mCherry) (Supp. Fig. 3(F)) and injected this
construct into zebraﬁsh embryos. mCherry-positive endothelial
cells co-expressing Su[H]DBM also mis-expressed nr2f2 in the
dorsal aorta, although no change was noted in neural tube
expression (Fig. 5(C) and (D)). Binary transgenic inducible expres-
sion of N3ICD did not alter expression of sox7 or sox18, indicating
that Notch does not regulate nr2f2 expression by modulating
expression of these SoxF family genes (Fig. 5(E)–(H)). Taken
together, these ﬁndings suggest that Notch works downstream
from or in parallel to sox7 and sox18 to repress nr2f2 expression in
the dorsal aorta.
Discussion
Our results suggest a model for upstream regulation of, and
downstream regulation by, nr2f2 during early arterial–venous
development in the zebraﬁsh trunk axial vasculature (Fig. 5). We
show that endothelial expression of nr2f2 requires endothelial
sox7 and sox18 gene function, while expression of some but not all
markers of venous identity requires nr2f2. Importantly, our results
also indicate that in addition to promoting arterial gene expres-
sion, Notch signaling in the dorsal aorta suppresses expression of
nr2f2, restricting nr2f2-dependent trunk vascular gene expression
to the cardinal vein.
The function of zebraﬁsh nr2f2 is required for proper venous
differentiation of the cardinal vein (Fig. 2(E)–(G) and (M)). Early
expression of prox1 and lyve1 is strongly reduced in nr2f2-
deﬁcient animals. However, other venous markers are either
modestly reduced (stab1) or unaffected (ephb4a, dab2). These
results are similar to those in previously published studies in
zebraﬁsh (Aranguren et al., 2011) and mice (You et al., 2005)
showing only partial effects on venous gene expression. It should
be noted that the translation blocking morpholino used in our
study is identical to that used in a previously published study
(Aranguren et al., 2011), and the exon 1 splice donor site morpho-
lino nearly identical (shifted 30 by one nucleotide). Levels of
endothelial Ephb4 are only slightly reduced in the cardinal veins
of Nr2f2/COUP-TFII knockout mice (You et al., 2005), while only
partial reduction is noted in venous expression of ﬂt4 and ephb4a
in nr2f2 knockdown zebraﬁsh (Aranguren et al., 2011). These
results suggest that factors in addition to nr2f2 may possibly be
required for full establishment of venous identity in both mice and
zebraﬁsh. Various reports have suggested that nr2f2/COUP-TFII
can act as either a repressor or an activator of downstream
gene expression (reviewed in (Park et al., 2003)). We examined
this in zebraﬁsh using endothelial-speciﬁc expression of either
wild type nr2f2, or nr2f2-engrailed (repressing) or nr2f2-VP16
Fig. 4. Sox gene function is required for nr2f2 expression in the zebraﬁsh vasculature. (A and B) Whole mount in situ hybridization of 24 hpf control (A) and sox7/sox18
double morpholino (DMO) injected (B) zebraﬁsh embryo trunks probed for nr2f2. The inset numbers in panels B show the number of in situ-stained embryos exhibiting
strongly reduced or absent vascular expression over the total number of embryos examined. (C) Quantitative RT-PCR measurement of nr2f2 and lyve1 gene expression in
excised trunks (see Materials and Methods) of 24 hpf control and sox7/sox18 DMO animals. (D) Quantitative RT-PCR measurement of nr2f2 gene expression in excised trunks
(see Materials and Methods) of 24 hpf control MO injected, sox7/sox18 DMO injected, clochemutant, and sox7/sox18 DMO injected clochemutant animals. All quantitative RT-
PCR values are shown normalized to control gene expression levels, which are set equal to 1. Rostral is to the left and dorsal is up in all image panels. Scale bars, 50 mm.
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(activating) fusion proteins, demonstrating that nr2f2 acts as a
cell-autonomous activator required for venous gene expression in
the zebraﬁsh, since endothelial expression of an nr2f2-engrailed
fusion protein (kdrl-ECt) results in reduced expression of lyve1 in a
manner similar to nr2f2 morpholino knockdown, while wild type
nr2f2 or an nr2f2-VP16 fusion protein has no signiﬁcant effect
(Fig. 3(B)–(F) and (Q)). These results suggest that, at least in this
context, nr2f2 is acting primarily as a positive factor for venous
gene expression.
Proper arterial–venous differentiation requires restricted expres-
sion of not only venous-speciﬁc genes but also arterial-speciﬁc genes.
A variety of previously published studies from our laboratory and
others have shown that Notch pathway activation promotes arterial
differentiation downstream from hedgehog and VEGF signaling
((Lawson et al., 2001; Lawson et al., 2002), reviewed in (Swift and
Weinstein, 2009)). In mice, COUP-TFII has been shown to act as a
negative regulator of Notch signaling to suppress arterial gene
expression in the cardinal vein (Chen et al., 2012; You et al., 2005).
Endothelial-cell speciﬁc ablation of COUP-TFII results in the formation
of vein-like structures that improperly express arterial markers
neuropilin 1 (Np1), Jag1, Hey1, Notch1, and Efnb2, along with the
partial reduction in expression of venous marker EphB4 noted above.
Conversely, mis-expression of COUP-TFII is developing arteries leads to
diminished expression of Np1 and Jag1 coincident with an increase in
EphB4 (You et al., 2005). More recently, microarray analysis in HUVEC
cells found the expression of several Notch target genes was regulated
by COUP-TFII and that COUP-TFII regulates foxc1, Np-1, and Hey2 at the
transcriptional level (Chen et al., 2012).
In contrast to these results, we ﬁnd no change in arterial-
speciﬁc gene expression in nr2f2-deﬁcient zebraﬁsh. Nr2f2
morpholino-injected animals show neither ectopic expansion of
arterial markers into the cardinal vein by in situ hybridization, nor
Fig. 5. Notch negatively regulates nr2f2 in the zebraﬁsh vasculature, but not via Sox. (A and B) Whole mount in situ hybridization of 24 hpf control (A) and Tg[ﬂi1a:GV-EcRF];
Tg[UAS:N3ICDmyc] double transgenic (B) animals treated with tebufenozide from 8 hpf to 28 hpf, probed for nr2f2. Blue arrowheads show the position of the posterior cardinal
vein. The inset numbers in panel B show the number of in situ-stained embryos exhibiting strongly reduced vascular expression over the total number of embryos examined.
(C and D) Whole mount in situ hybridization of 24 hpf control (C) and kdrl:Su[H]DBM-2A-mCherry injected (D) animals, probed for nr2f2. Blue arrowheads show position of the
posterior cardinal vein, red arrowheads show ectopic nr2f2 expression in the dorsal aorta. The inset numbers in panel D show the number of in situ-stained embryos exhibiting
patches of strong ectopic nr2f2 expression in the dorsal aorta over the total number of embryos examined. (E–H) Whole mount in situ hybridization of 24 hpf control (E and G)
and Tg[ﬂi1a:GV-EcRF];Tg[UAS:N3ICDmyc] double transgenic (F and H) animals treated with tebufenozide from 8 hpf to 24 hpf, probed for sox7 (E and F) or sox18 (G,H). The inset
numbers in panels F and H show the number of N3ICDmyc-expressing in situ-stained embryos exhibiting sox7 or sox18 expression comparable to that in controls, over the total
number of embryos examined. Rostral is to the left and dorsal is up in all image panels. Scale bars, 100 mm.
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increased trunk expression of these genes as measured by quanti-
tative RT-PCR (Fig. 2(I)–(K) and (M)). Again, these results are
consistent with a previously published report showing lack of
ectopic expression of arterial markers in veins in nr2f2 knockdown
zebraﬁsh (Aranguren et al., 2011). In addition to the morpholino
knockdown ﬁndings, we fail to observe either ectopic venous
expression or increased overall expression of arterial marker
efnb2a in zebraﬁsh expressing the “repressing” kdrl-ECt fusion
protein speciﬁcally in the endothelium (Fig. 3(O) and (Q)), despite
strongly reduced expression of the venous marker lyve1 in these
same animals (Fig. 3(E) and (Q)). We used two different Notch-
responsive transgenic zebraﬁsh reporter lines to look more
directly at the effects of either nr2f2 morpholino knockdown or
endothelial-speciﬁc expression of nr2f2 fusion proteins on Notch
activation. Expression of ﬂuorescent reporters was not affected by
functional manipulation of nr2f2 in Tg(Tp1bglob:hmgb1-mCher-
ry)h11 or Tg(efnb2a:eGFP) transgenic animals (Fig. 3(G)–(K) and
Supp. Fig. 4), despite the fact that arterial expression of both
reporters is clearly Notch-responsive as indicated by reduced
expression upon treatment with DAPT (Supp. Fig. 5). Taken
together, these results suggest that nr2f2 is not required to
modulate Notch signaling activity or suppress arterial-speciﬁc
gene expression in the zebraﬁsh cardinal vein.
We examined other potential factors that might be responsible
for promoting venous identity or suppressing arterial identity in
the cardinal vein. A number of recent studies have reported that
the soxF family members sox7 and sox18modulate arterial–venous
differentiation in the zebraﬁsh, although the precise nature of
their role remains somewhat unclear, with effects on expression of
either arterial genes, venous genes, or both noted in different
reports (Cermenati et al., 2008; Herpers et al., 2008; Pendeville
et al., 2008). A recent publication suggests that Sox and Notch are
required together for full expression of at least on arterial gene,
Dll4 (Sacilotto et al., 2013). We ﬁnd that sox7/18 function promotes
expression of at least some of the same genes dependent on nr2f2
(Fig. 4). As noted in one of those previous publications (Cermenati
et al., 2008;), sox7 and sox18 appear to function redundantly in the
regulating vein identity, since double morphants show loss of
venous gene expression while single morphants do not. Interest-
ingly, the other two studies (Herpers et al., 2008; Pendeville et al.,
2008) reported ectopic expression of the venous marker ﬂt4 in the
DA, however these studies did not examine expression beyond a
single time point to see if this altered expression persists. We ﬁnd
that sox7/18 function is required for expression of nr2f2 in the
cardinal vein, suggesting that sox7/18 function is required
upstream of nr2f2 to regulate proper venous differentiation.
While sox7 and sox18 are required for nr2f2 expression and for
proper arterial–venous differentiation, it seems unlikely that these
genes are acting as “selective factors” for promoting distinct
endothelial cell fates in the dorsal aorta and cardinal vein. Nr2f2
is expressed only in the cardinal vein, not in the dorsal aorta, while
the two sox genes are each expressed in both the cardinal vein and
the dorsal aorta during early trunk axial vessel arterial–venous
differentiation. The arterial expression of sox7 and sox18 (but not
nr2f2) suggests that some other factor(s) in addition to sox7 and
sox18 is either necessary to suppress nr2f2 expression in the dorsal
aorta or required for nr2f2 expression in the posterior cardinal
vein. Surprisingly, we have now found that Notch signaling
appears to be acting as an arterial-speciﬁc suppressor of nr2f2
expression and venous identity in zebraﬁsh. Using both whole
organism and EC-speciﬁc gain-of-function experiments to mis-
express Notch ICD, we ﬁnd a consistent and signiﬁcant loss of
nr2f2 expression in the PCV (Fig. 5(A) and (B)). Mis-expression of
“activated” Notch ICD does not result in altered expression of
either sox7 or sox18, conﬁrming that Notch does not regulate nr2f2
expression by modulating levels of sox7 or sox18 (Fig. 5(E)–(H)).
Conversely, endothelial-speciﬁc suppression of Notch signaling
using a dominant negative suppressor of Hairless (Su(H)) DNA
binding mutant driven by the kdrl promoter results in ectopic
expression of nr2f2 in the dorsal aorta (Fig. 5(C) and (D)).
Conclusions
Together, these results suggest that Notch serves as an arterial-
speciﬁc repressor of nr2f2 expression in the zebraﬁsh endothelium
(Fig. 6). Our ﬁndings lead us to hypothesize that Notch signaling
functions as a “switch” regulating both arterial and venous gene
expression and identity. In the dorsal aorta, the presence of active
Notch signaling serves a dual function to simultaneously promote
arterial gene expression and suppress nr2f2-driven venous gene
expression. In the cardinal vein, absence of Notch signaling
prevents arterial gene expression but permits expression of nr2f2
and nr2f2-dependent venous gene expression. Although at least
one previous study suggests that Notch may directly regulate
activity of the NR2F2 promoter, our data do not establish whether
suppression of nr2f2 in the zebraﬁsh dorsal aorta is direct or due
to the activity of less proximal downstream genes up-regulated in
the dorsal aorta by Notch.
This model is satisfying in terms of explaining how sox7 and
sox18, which are both expressed in a pan-endothelial fashion, can
be required upstream of nr2f2, which is expressed only in venous
but not in arterial venous vessels. However, it is clearly an over-
simpliﬁcation of what is likely to be a more complex regulatory
network. nr2f2 and sox7/18 function appear to be required for the
expression of only a subset of venous-speciﬁc genes, and they also
appear to also affect some arterial-speciﬁc gene expression (parti-
cularly for sox7/18; Herpers et al., 2008; Pendeville et al., 2008).
Likewise, the effects of Notch signaling are also not absolute with
regard to arterial identity, as previously published results from our
laboratory and others have shown that some arterial-speciﬁc
markers remain unresponsive to manipulation of Notch function
(Lawson et al., 2001; Lawson et al., 2002). Nevertheless, our results
generally support the role of Notch signaling as a key nexus for the
arterial–venous fate decision in the zebraﬁsh, not only through
promotion of arterial differentiation but also through suppression
of nr2f2-dependent venous differentiation.
Fig. 6. A proposed model for the regulation and functional role of nr2f2 in the early
zebraﬁsh trunk vasculature. The function of nr2f2 is required for some, but not all,
venous gene expression in the posterior cardinal vein (PCV), most likely as a
positive-acting or permissive factor. Nr2f2 expression itself is positively regulated
by the combined activity of sox7 and sox18, each of which are expressed in both
the venous and arterial vasculature. Although Notch does not appear to be
regulated downstream from nr2f2 during early zebraﬁsh vascular development,
Notch signaling activity suppresses expression of nr2f2 in the dorsal aorta, either
directly or indirectly, resulting in restriction of nr2f2 expression to the posterior
cardinal vein.
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